Federal Register / Vol. 74, No. 67 / Thursday, April 9, 2009 / Notices 16223 

Bethesda, MD 20894. 301–496–6921. 

Sheldon Kotzin@nlm.nih.gov. 

Any interested person may file written 

comments with the Committee by forwarding 

the statement to the Contact Person listed on 

this Notice. The statement should include the 

name, address, telephone number and, when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by nongovernment 

employees. Persons without a government 

I.D. will need to show a photo ID. and sign 

in at the security desk upon entering the 

building. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.879, Medical Library 

Assistance, National Institutes of Health, I– 

IHS) 

Dated: March 31, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy, NIH. 

[FR Doc. E9–7731 Filed 4–8–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of a Meeting of a Working 

Group of the NIH Blue Ribbon Panel 

The purpose of this notice is to inform 

the public about a meeting of the NIH 

Blue Ribbon Panel to Advise on the Risk 

Assessment of the National Emerging 

Infectious Diseases Laboratories at 

Boston University Medical Center. 

The meeting will be held Tuesday, 

May 5, 2009 at the National Institutes of 

Health, Building 31, 31 Center Drive, 

Floor 6C, Room 6, Bethesda, MD 20892 

from approximately 9 a.m. to 12 p.m. 

The purpose of the meeting is for the 

Panel to review and discuss progress on 

the supplementary risk assessment 

being conducted for the Boston 

University NEIDL. The National 

Research Council Committee on 

Technical Input will participate in this 

discussion and provide its views. 

Public comment will begin at 

approximately 11:30 a.m. In the event 

that time does not allow for all those 

interested to present oral comments, 

anyone may file written comments by 

sending them to the address below. 

Comments should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the commenter. 

The meeting will be open to the 

public, with attendance limited to space 

available. There will be a live Web cast 

of the meeting which can be accessed at 

http://nihblueribbonpanel-bumcneidl.od.nih.gov/. Individuals who plan 

to attend and need special assistance, 

such as sign language interpretation or 

other reasonable accommodations, 

should notify the Contact Person listed 

below in advance of the meeting. 

In the interest of security, NIH has 

instituted stringent procedures for 

entrance onto the NIH campus. All 

visitor vehicles, including taxicabs, 

hotel, and airport shuttles will be 

inspected before being allowed on 

campus. Visitors will be asked to show 

one form of identification (for example, 

a government-issued photo ID, driver’s 

license, or passport) and to state the 

purpose of their visit. 

A draft agenda and slides for the 

meeting may be obtained by connecting 

to http://nihblueribbonpanel-bumcneidl.od.nih.gov/. For additional 

information concerning this meeting, 

contact Ms. Laurie Lewallen, Advisory 

Committee Coordinator, Office of 

Biotechnology Activities, Office of 

Science Policy, Office of the Director, 

National Institutes of Health, 6705 

Rockledge Drive, Room 750, Bethesda, 

MD 20892–7985; telephone 301–496– 

9838; e-mail lewallenl@od.nih.gov. 

Dated: April 2, 2009. 

Amy P. Patterson, 

Acting Director, Office of Science Policy, 

National Institutes of Health. 

[FR Doc. E9–8009 Filed 4–8–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Fiscal Year (FY) 2009 Funding 

Opportunity 

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS. 

ACTION: Notice of intent to award a 

Single Source Grant to Case 

Management, Inc. (CMI), Memphis, TN. 

SUMMARY: This notice is to inform the 

public that the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) intends to award 

approximately $500,000 (total costs) per 

year for up to two years to Case 

Management, Inc. (CMI), Memphis, TN. 

This is not a formal request for 

applications. Assistance will be 

provided only to Case Management, Inc. 

(CMI) based on the receipt of a 

satisfactory application that is approved 

by an independent review group. 

Funding Opportunity Title: Services 

Grant Program for Residential Treatment 

for Pregnant and Postpartum Women— 

Babylove II; TI–09–009. 

Catalog of Federal Domestic 

Assistance (CFDA) Number: 93.243. 

Authority: Section 508 of the Public Health 

Service Act, as amended. 

Justification: Only Case Management, 

Inc. (CMI) is eligible to apply. The 

Substance Abuse and Mental Health 

Services Administration (SAMHSA) is 

seeking to award a single source grant 

to Case Management, Inc. (CMI) to carry 

out the remainder of the CSAT-funded 

FY 2008 PPW Babylove II Project. 

Midtown Mental Health Center 

(MMHC), the recipient of an FY 2008 

CSAT PPW grant award, notified 

SAMHSA that it: had ceased business; 

had been recently acquired by Case 

Management, Inc. (CMI); and transferred 

its contacts and patients to CMI effective 

September 16, 2008. Furthermore, CMI 

had assumed all of MMHC’s existing 

obligations under patient care contracts 

and/or grants. This transfer included 

relinquishing the FY 2008 CSAT PPW 

grant award issued on September 1, 

2008, and transferring all associated 

patient services provided by the 

SAMHSA/CSAT grant-funded Babylove 

II Program. 

The Babylove II PPW Project is 

currently the only program in West 

Tennessee that provides specialized 

long-term residential treatment services 

for pregnant and postpartum women 

with co-occurring disorders, where the 

children can reside in the residential 

treatment facility with their mothers. 

CMI has been approved by SAMHSA/ 

CSAT Grants Management as the 

replacement grantee for the remainder 

of the current budget period (12/16/08– 

9/29/09). According to the Awarding 

Agency Grants Administration Manual 

(AAGAM), as a replacement grantee, 

CMI is not automatically approved for 

the future budget years (i.e., years 2 and 

3). This sole source grant will cover the 

future budget years of this 3 year grant 

program. 

Contact: Shelly Hara, Substance 

Abuse and Mental Health Services 

Administration, 1 Choke Cherry Road, 

Room 8–1081, Rockville, MD 20857; 

telephone: (240) 276–2321; e-mail: 

shelly.hara@samhsa.hhs.gov. 

Toian Vaughn, 

SAMHSA Committee Management Officer. 

[FR Doc. E9–8053 Filed 4–8–09; 8:45 am] 

BILLING CODE 4162–20–P 


dwashington3 on PROD1PC60 with NOTICES